2018
DOI: 10.1002/cncr.31732
|View full text |Cite
|
Sign up to set email alerts
|

Pregnancy after cancer: Does timing of conception affect infant health?

Abstract: BACKGROUND:The objective of this retrospective cohort study was to determine whether women who conceive soon after treatment for cancer have higher risks of adverse pregnancy outcomes. METHODS: Vital records data were linked to cancer registry diagnosis and treatment information in 3 US states. Women who conceived their first pregnancy after diagnosis between ages 20 and 45 years with any invasive cancer or ductal carcinoma in situ were eligible. Log-binomial models were used to compare risks in cancer survivo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
39
3
5

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 60 publications
(51 citation statements)
references
References 23 publications
(33 reference statements)
4
39
3
5
Order By: Relevance
“…Similar results were observed among breast cancer survivors for both preterm birth (RR, 2.4; 95% CI, 1.4-4.0) and low birth weight (RR, 3.3; 95% CI, 1.9-5.8). 107 On the contrary, breast cancer patients who conceived between 12 to 24 months after treatment did not have higher risks of preterm birth (RR, 0.9; 95% CI, 0.4-2.0) or infants born small for gestational age (RR, 0.8; 95% CI, 0.3-1.8) than matched women without cancer. 107 Taken together (Table 5), these studies suggest that despite there is no optimal cut-off to plan a pregnancy following breast cancer diagnosis, attempts to conceptions should be postponed at least 12 months following chemotherapy completion.…”
Section: Is It Safe To Interrupt Endocrine Therapy With the Aim To Hamentioning
confidence: 94%
See 2 more Smart Citations
“…Similar results were observed among breast cancer survivors for both preterm birth (RR, 2.4; 95% CI, 1.4-4.0) and low birth weight (RR, 3.3; 95% CI, 1.9-5.8). 107 On the contrary, breast cancer patients who conceived between 12 to 24 months after treatment did not have higher risks of preterm birth (RR, 0.9; 95% CI, 0.4-2.0) or infants born small for gestational age (RR, 0.8; 95% CI, 0.3-1.8) than matched women without cancer. 107 Taken together (Table 5), these studies suggest that despite there is no optimal cut-off to plan a pregnancy following breast cancer diagnosis, attempts to conceptions should be postponed at least 12 months following chemotherapy completion.…”
Section: Is It Safe To Interrupt Endocrine Therapy With the Aim To Hamentioning
confidence: 94%
“…107 On the contrary, breast cancer patients who conceived between 12 to 24 months after treatment did not have higher risks of preterm birth (RR, 0.9; 95% CI, 0.4-2.0) or infants born small for gestational age (RR, 0.8; 95% CI, 0.3-1.8) than matched women without cancer. 107 Taken together (Table 5), these studies suggest that despite there is no optimal cut-off to plan a pregnancy following breast cancer diagnosis, attempts to conceptions should be postponed at least 12 months following chemotherapy completion. A wash-out period of 3 and 7 months should be also considered following exposure to endocrine therapy and anti-HER2 biologic agents, respectively.…”
Section: Is It Safe To Interrupt Endocrine Therapy With the Aim To Hamentioning
confidence: 94%
See 1 more Smart Citation
“…Таким образом, был сделан вывод о необходимости наблюдения за пациентками минимум в течение 6 месяцев после постановки диагноза и до наступления беременности. Однако авторы также рекомендуют для женщин с более высоким риском рецидива рассмотреть отсрочку беременности на срок 5 лет и более [34].…”
Section: оптимальные сроки планирования беременности после лечения раunclassified
“…In this issue of Cancer , Hartnett and colleagues seek to address this gap and build on the existing literature by evaluating fetal outcomes in a large population‐based sample of women with a history of cancer . They present an analysis of first subsequent pregnancy outcomes among women who were diagnosed with cancer between ages 20 and 45 years in 3 US states using cancer registry data linked to birth registries.…”
mentioning
confidence: 99%